The targeting behavior of folate-nanohydrogel evaluated by near infrared imaging system in tumor-bearing mouse model

Pharm Res. 2010 Jan;27(1):46-55. doi: 10.1007/s11095-009-0005-1. Epub 2009 Nov 11.

Abstract

Purpose: To synthesize P[(Folate-Allylamine)-co-(N-isopropylacrylamine)- co-Acrylamide] (P(FoAAn-co-NIPA-AAm), folate-NHG) with appropriate diameter and lower critical solution temperature (LCST) for targeting to folate receptor (FR) expressing tumors.

Methods: Folate-NHG was synthesized by free-radical precipitation polymerization method reported in our previous work and other reports. LCST, diameter and morphology of folate-NHG were characterized by UV-vis spectrophotometer, laser particle size analyzer (LPSA) and transmission electron microscope (TEM), respectively. No.12 near infrared dye (NIRD-12) was entrapped into folate-NHG by hydrophobic association to trace the in vivo dynamic behavior of folate-NHG. This process was evaluated by a homemade near infrared (NIR) imaging system.

Results: Spherical folate-NHG with diameter of about 50 nm and LCST of about 40 degrees C was successfully synthesized. The photo stability of NIRD-12 was strengthened after being entrapped into folate-NHG, which enabled NIRD-12 to better trace the in vivo dynamic process of folate-NHG. Folate-NHG showed good targeting capability for all three folate receptor expressing tumor models (SMMC-7721, Bel-7402 and HeLa) with different sizes, and this accumulation could last for more than 96 h. D-folate-NHG, synthesized with double amount of FoAAn, showed better targeting effect for SMMC-7721 tumor model than that of folate-NHG.

Conclusions: Folate-NHG could actively accumulate in three models of folate receptor positive tumors with different sizes and keep retention for more than 96 h, which enables it to be used as a diagnostic reagent or anti-tumor drug carrier for tumor therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Drug Carriers / chemical synthesis
  • Drug Carriers / pharmacokinetics
  • Drug Carriers / therapeutic use
  • Drug Delivery Systems / methods*
  • Folic Acid* / chemistry
  • Folic Acid* / pharmacokinetics
  • Folic Acid* / therapeutic use
  • Humans
  • Hydrogels / chemical synthesis*
  • Hydrogels / pharmacokinetics
  • Mice
  • Mice, Nude
  • Nanotechnology / methods*
  • Neoplasms / drug therapy
  • Particle Size
  • Tissue Distribution
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Hydrogels
  • Folic Acid